Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ahmed Sallam

Concepts (322)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitrectomy
26
2023
49
8.150
 Why?
Cataract
11
2024
46
6.640
 Why?
Macular Edema
14
2023
25
6.050
 Why?
Cataract Extraction
12
2024
30
5.580
 Why?
Diabetic Retinopathy
9
2023
41
4.890
 Why?
Retinal Detachment
12
2023
23
4.660
 Why?
Phacoemulsification
12
2023
30
4.500
 Why?
Visual Acuity
28
2022
143
4.480
 Why?
Uveitis
11
2023
28
4.050
 Why?
Ophthalmology
8
2023
40
4.010
 Why?
Endophthalmitis
11
2023
30
3.530
 Why?
Glucocorticoids
15
2023
234
3.410
 Why?
Intraoperative Complications
13
2024
125
3.190
 Why?
Dexamethasone
9
2023
435
2.900
 Why?
Drug Implants
9
2023
35
2.650
 Why?
Epiretinal Membrane
4
2023
9
2.570
 Why?
Tomography, Optical Coherence
16
2023
148
2.310
 Why?
Hordeum
3
2022
5
2.270
 Why?
Diabetes Mellitus
4
2022
309
2.070
 Why?
Retinal Vein Occlusion
6
2023
12
2.050
 Why?
Eye Infections, Fungal
6
2021
22
2.050
 Why?
Vitreoretinal Surgery
4
2019
8
2.010
 Why?
Papilledema
4
2022
28
2.010
 Why?
Retrospective Studies
39
2024
6432
1.970
 Why?
Eye Infections, Bacterial
6
2023
35
1.890
 Why?
Humans
100
2024
54284
1.840
 Why?
Triticum
3
2023
10
1.790
 Why?
Fluorocarbons
3
2023
52
1.580
 Why?
Fibrin
2
2023
14
1.540
 Why?
Angiogenesis Inhibitors
7
2022
203
1.530
 Why?
Retinal Diseases
7
2021
49
1.520
 Why?
Paracentesis
2
2023
10
1.520
 Why?
Intravitreal Injections
15
2023
40
1.510
 Why?
Postoperative Complications
10
2023
1033
1.430
 Why?
Tissue Plasminogen Activator
2
2023
124
1.400
 Why?
Glaucoma
4
2023
64
1.390
 Why?
Lenses, Intraocular
2
2022
7
1.360
 Why?
Macular Degeneration
4
2024
49
1.350
 Why?
Retinal Perforations
4
2023
7
1.300
 Why?
Syphilis
3
2023
25
1.230
 Why?
Iris Diseases
3
2020
6
1.210
 Why?
Retina
6
2024
64
1.180
 Why?
Wet Macular Degeneration
3
2022
15
1.180
 Why?
Candidiasis
3
2021
122
1.150
 Why?
Societies, Medical
3
2019
194
1.100
 Why?
Lens Implantation, Intraocular
6
2021
22
1.060
 Why?
Choroid
4
2020
26
1.000
 Why?
Endotamponade
4
2018
9
1.000
 Why?
Aged
31
2023
10054
1.000
 Why?
Lighting
1
2024
4
0.980
 Why?
Lens, Crystalline
1
2024
17
0.960
 Why?
Anterior Chamber
1
2023
10
0.960
 Why?
Male
46
2023
27334
0.950
 Why?
Triamcinolone Acetonide
5
2011
16
0.940
 Why?
Panuveitis
2
2021
6
0.940
 Why?
Ocular Hypertension
2
2016
13
0.930
 Why?
Middle Aged
32
2023
13088
0.930
 Why?
Aged, 80 and over
20
2023
3431
0.930
 Why?
Germination
1
2023
6
0.910
 Why?
Intraocular Pressure
7
2020
89
0.890
 Why?
Occlusive Dressings
1
2022
7
0.890
 Why?
State Medicine
5
2023
17
0.870
 Why?
Female
45
2023
28441
0.870
 Why?
HIV Seropositivity
1
2022
28
0.870
 Why?
Comprehension
1
2023
115
0.860
 Why?
Antihypertensive Agents
2
2016
139
0.850
 Why?
Optic Neuropathy, Ischemic
1
2022
9
0.850
 Why?
Eye Foreign Bodies
1
2022
10
0.840
 Why?
Databases, Factual
6
2021
684
0.840
 Why?
Enbucrilate
1
2021
6
0.840
 Why?
Tissue Adhesives
1
2021
15
0.840
 Why?
Varicose Veins
2
2019
18
0.800
 Why?
Stress, Physiological
2
2019
194
0.790
 Why?
Candida
4
2020
67
0.770
 Why?
Choroiditis
1
2020
10
0.770
 Why?
Retinal Vein
2
2019
3
0.730
 Why?
Eyeglasses
1
2019
10
0.720
 Why?
Photography
4
2013
39
0.720
 Why?
Crohn Disease
1
2020
96
0.710
 Why?
Trichoderma
1
2019
1
0.710
 Why?
Surgical Instruments
1
2019
34
0.710
 Why?
Pseudophakia
5
2023
11
0.710
 Why?
Plant Diseases
1
2019
13
0.710
 Why?
Anesthesia, General
2
2022
96
0.710
 Why?
Suture Techniques
2
2022
70
0.690
 Why?
Fovea Centralis
1
2018
5
0.670
 Why?
Laser Therapy
1
2019
91
0.670
 Why?
Basement Membrane
1
2018
22
0.670
 Why?
Imaging, Three-Dimensional
1
2019
171
0.650
 Why?
National Health Programs
2
2015
17
0.650
 Why?
Vascular Endothelial Growth Factor A
5
2022
230
0.640
 Why?
HIV Infections
1
2022
394
0.640
 Why?
Eye Injuries
2
2009
29
0.630
 Why?
Egypt
4
2022
14
0.630
 Why?
Fluocinolone Acetonide
1
2017
6
0.630
 Why?
Air
2
2016
26
0.610
 Why?
Droughts
3
2023
7
0.580
 Why?
Prospective Studies
8
2024
2604
0.580
 Why?
Minerals
1
2016
36
0.570
 Why?
Follow-Up Studies
9
2021
2387
0.570
 Why?
Treatment Outcome
12
2023
5604
0.570
 Why?
Vitreous Detachment
1
2016
1
0.560
 Why?
Sodium Chloride
1
2016
67
0.560
 Why?
Acetates
1
2016
50
0.560
 Why?
Dissection
1
2016
19
0.560
 Why?
Adult
20
2022
14207
0.550
 Why?
Ophthalmologic Surgical Procedures
1
2016
27
0.540
 Why?
Registries
2
2018
553
0.540
 Why?
Anesthesia, Local
1
2015
19
0.530
 Why?
Adrenergic alpha-1 Receptor Antagonists
2
2020
8
0.530
 Why?
Sclera
1
2014
6
0.500
 Why?
Fluorescein Angiography
5
2024
30
0.470
 Why?
Eye Diseases
2
2016
35
0.470
 Why?
Device Removal
1
2014
97
0.460
 Why?
Iris
3
2022
10
0.440
 Why?
Child
9
2024
7341
0.430
 Why?
Vitreous Body
5
2020
16
0.420
 Why?
Scleral Buckling
3
2023
4
0.410
 Why?
Physical Examination
2
2013
99
0.410
 Why?
Optic Disk
2
2021
25
0.400
 Why?
Mydriatics
1
2011
14
0.400
 Why?
Microscopy
1
2011
66
0.390
 Why?
Incidence
9
2021
1082
0.380
 Why?
Seasons
2
2022
98
0.370
 Why?
Genotype
2
2023
599
0.350
 Why?
Intraoperative Period
2
2019
51
0.350
 Why?
Fibrinolytic Agents
2
2023
139
0.350
 Why?
Lens Capsule, Crystalline
2
2016
2
0.340
 Why?
Adrenergic alpha-Antagonists
1
2008
24
0.330
 Why?
Silicone Oils
3
2023
3
0.320
 Why?
Chorioretinitis
2
2021
8
0.320
 Why?
Physicians, Family
1
2008
35
0.320
 Why?
Eye Infections, Viral
1
2008
2
0.320
 Why?
Ocular Hypotension
1
2008
3
0.320
 Why?
Eye Infections, Parasitic
1
2008
2
0.320
 Why?
Vision Disorders
3
2022
73
0.320
 Why?
Suction
1
2008
22
0.320
 Why?
Choroid Neoplasms
1
2007
7
0.320
 Why?
Child, Preschool
7
2020
4147
0.310
 Why?
Eye Burns
1
2007
1
0.310
 Why?
Ophthalmic Solutions
1
2007
27
0.300
 Why?
Hyaluronic Acid
1
2007
32
0.300
 Why?
Sulfonamides
1
2008
146
0.300
 Why?
Anti-Infective Agents
1
2008
110
0.290
 Why?
Cohort Studies
2
2022
1543
0.240
 Why?
Melanoma
1
2007
313
0.240
 Why?
Tattooing
1
2023
4
0.240
 Why?
Sex Workers
1
2023
2
0.230
 Why?
Cultural Diversity
1
2023
30
0.230
 Why?
Health Knowledge, Attitudes, Practice
1
2008
543
0.230
 Why?
Geographic Atrophy
1
2023
9
0.230
 Why?
Fibrinolysin
1
2023
2
0.230
 Why?
Drainage
1
2023
79
0.230
 Why?
Young Adult
7
2021
4318
0.230
 Why?
Inflammation
3
2022
674
0.230
 Why?
Adolescent
7
2022
6897
0.230
 Why?
Retreatment
2
2014
57
0.230
 Why?
Schools, Medical
1
2023
82
0.230
 Why?
Vaccination
2
2022
294
0.220
 Why?
Reproducibility of Results
3
2023
1304
0.220
 Why?
Subretinal Fluid
1
2022
1
0.220
 Why?
Blood-Retinal Barrier
1
2022
6
0.220
 Why?
Faculty, Medical
1
2023
100
0.220
 Why?
Privacy
1
2022
18
0.220
 Why?
Disease Management
2
2021
184
0.210
 Why?
Treponema pallidum
2
2023
10
0.210
 Why?
Cyanoacrylates
1
2021
8
0.210
 Why?
Fibrin Tissue Adhesive
1
2021
12
0.210
 Why?
Recombinant Fusion Proteins
1
2022
206
0.210
 Why?
Eye Abnormalities
1
2021
22
0.210
 Why?
Vision, Ocular
1
2021
13
0.210
 Why?
Prednisone
1
2022
111
0.210
 Why?
Antibodies, Monoclonal, Humanized
2
2015
240
0.210
 Why?
United States
3
2023
5217
0.210
 Why?
Eye
1
2021
36
0.200
 Why?
Ecosystem
1
2022
91
0.200
 Why?
Prolapse
1
2020
7
0.200
 Why?
Fungemia
1
2021
36
0.200
 Why?
Tomography, X-Ray Computed
2
2022
1213
0.190
 Why?
Randomized Controlled Trials as Topic
1
2024
596
0.190
 Why?
Electronic Health Records
3
2018
206
0.190
 Why?
Oximetry
2
2011
62
0.190
 Why?
Anti-Bacterial Agents
4
2021
820
0.190
 Why?
Ophthalmoscopy
1
2020
19
0.190
 Why?
Swine
1
2021
431
0.190
 Why?
Macula Lutea
1
2020
6
0.190
 Why?
Carcinoma, Hepatocellular
1
2022
203
0.180
 Why?
Retinal Pigment Epithelium
1
2020
24
0.180
 Why?
Substance Abuse, Intravenous
1
2020
44
0.180
 Why?
Bacteria
1
2022
258
0.180
 Why?
Fusariosis
1
2019
6
0.180
 Why?
Plant Roots
1
2019
37
0.180
 Why?
Fusarium
1
2019
29
0.180
 Why?
Polymorphism, Single Nucleotide
1
2022
552
0.170
 Why?
Quantitative Trait Loci
1
2019
51
0.170
 Why?
Risk Factors
6
2021
3935
0.170
 Why?
Hepatitis C
1
2020
94
0.170
 Why?
Referral and Consultation
3
2013
307
0.170
 Why?
Emergencies
2
2009
92
0.170
 Why?
Chromosome Mapping
1
2019
175
0.170
 Why?
Liver Neoplasms
1
2022
352
0.170
 Why?
Antibiotic Prophylaxis
1
2019
67
0.170
 Why?
MicroRNAs
1
2022
386
0.160
 Why?
Water
1
2019
102
0.160
 Why?
Equipment Design
1
2019
318
0.160
 Why?
Gaucher Disease
1
2018
17
0.160
 Why?
Alleles
1
2019
277
0.160
 Why?
Cross-Sectional Studies
1
2023
1693
0.160
 Why?
Surgical Wound Infection
1
2019
126
0.160
 Why?
Sulfur Hexafluoride
1
2017
3
0.160
 Why?
Recurrence
2
2011
690
0.160
 Why?
Treatment Failure
1
2018
139
0.160
 Why?
Prevalence
2
2018
1025
0.150
 Why?
Drug Therapy, Combination
2
2016
426
0.150
 Why?
Retinitis
1
2017
3
0.150
 Why?
Eye Diseases, Hereditary
1
2017
6
0.150
 Why?
Inheritance Patterns
1
2017
27
0.150
 Why?
Penicillins
1
2017
29
0.150
 Why?
Fatty Acids
1
2018
174
0.150
 Why?
Contrast Media
1
2018
221
0.150
 Why?
Drug Combinations
1
2016
128
0.140
 Why?
Video Recording
1
2016
90
0.140
 Why?
Time Factors
3
2020
3213
0.140
 Why?
Phenotype
1
2019
820
0.140
 Why?
Anesthetics, General
1
2015
4
0.130
 Why?
Infant
3
2015
3817
0.130
 Why?
Visually Impaired Persons
1
2015
2
0.130
 Why?
Vision, Low
1
2015
8
0.130
 Why?
Blindness
1
2015
32
0.130
 Why?
England
2
2012
61
0.130
 Why?
Anesthetics, Local
1
2015
74
0.130
 Why?
Dose-Response Relationship, Drug
2
2016
1476
0.130
 Why?
Acute Disease
2
2021
403
0.120
 Why?
Microscopy, Acoustic
1
2013
6
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2013
22
0.120
 Why?
Glaucoma, Neovascular
1
2012
3
0.110
 Why?
Infusions, Intravenous
2
2017
231
0.110
 Why?
Diagnosis, Differential
3
2017
1136
0.110
 Why?
Syndrome
2
2011
252
0.100
 Why?
Retinal Vessels
1
2011
13
0.100
 Why?
Muscle Hypotonia
1
2011
24
0.100
 Why?
Risperidone
1
2011
25
0.100
 Why?
Risk Assessment
1
2016
1361
0.100
 Why?
Fundus Oculi
2
2021
24
0.100
 Why?
Eye Hemorrhage
1
2010
2
0.090
 Why?
Cranial Sinuses
1
2010
11
0.090
 Why?
Carotid Artery Injuries
1
2010
14
0.090
 Why?
Mutation
1
2017
1501
0.090
 Why?
Arteriovenous Fistula
1
2010
26
0.090
 Why?
Prostaglandins F, Synthetic
1
2009
2
0.090
 Why?
Tonometry, Ocular
1
2009
14
0.090
 Why?
Anti-Inflammatory Agents
1
2011
175
0.090
 Why?
Prednisolone
1
2009
57
0.090
 Why?
Carbonic Anhydrase Inhibitors
1
2008
5
0.090
 Why?
Acetazolamide
1
2008
20
0.080
 Why?
Antipsychotic Agents
1
2011
247
0.080
 Why?
Pupil
1
2008
32
0.080
 Why?
Vitreous Hemorrhage
1
2008
5
0.080
 Why?
Prostatic Hyperplasia
1
2008
44
0.080
 Why?
Injections
1
2008
61
0.080
 Why?
Oxygen
1
2011
361
0.080
 Why?
Electroretinography
2
2018
20
0.080
 Why?
Microsurgery
1
2008
35
0.080
 Why?
Cefuroxime
1
2007
4
0.080
 Why?
Mass Screening
1
2011
370
0.080
 Why?
Cefazolin
1
2007
11
0.080
 Why?
Capsulorhexis
1
2007
1
0.080
 Why?
Rupture
1
2007
31
0.080
 Why?
Astigmatism
1
2007
6
0.080
 Why?
Models, Biological
1
2011
823
0.080
 Why?
Neoplasm Metastasis
1
2007
252
0.070
 Why?
Chronic Disease
1
2009
614
0.070
 Why?
Animals
1
2021
14385
0.070
 Why?
Clinical Competence
1
2008
446
0.060
 Why?
Antifungal Agents
1
2006
363
0.060
 Why?
Homosexuality, Male
1
2023
56
0.060
 Why?
Retinal Ganglion Cells
1
2022
23
0.050
 Why?
Traction
1
2021
6
0.050
 Why?
Reoperation
2
2014
454
0.050
 Why?
Socioeconomic Factors
1
2023
642
0.050
 Why?
Health Status Disparities
1
2023
219
0.050
 Why?
Atrophy
1
2020
40
0.050
 Why?
Healthcare Disparities
1
2023
271
0.040
 Why?
Europe
1
2019
102
0.040
 Why?
Glucosylceramidase
1
2018
11
0.040
 Why?
Administration, Oral
2
2011
459
0.040
 Why?
Enzyme Replacement Therapy
1
2018
19
0.040
 Why?
Transplantation, Autologous
1
2020
476
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2022
866
0.040
 Why?
Visual Fields
1
2018
56
0.040
 Why?
Prone Position
1
2017
38
0.040
 Why?
Consanguinity
1
2017
15
0.040
 Why?
Genes, Recessive
1
2017
18
0.040
 Why?
Heterozygote
1
2017
96
0.040
 Why?
Pedigree
1
2017
146
0.040
 Why?
DNA Mutational Analysis
1
2017
217
0.040
 Why?
Recombinant Proteins
1
2018
569
0.040
 Why?
Genetic Association Studies
1
2017
136
0.040
 Why?
Genetic Testing
1
2017
135
0.040
 Why?
Rupture, Spontaneous
1
2016
26
0.040
 Why?
Practice Guidelines as Topic
1
2019
492
0.030
 Why?
Pregnancy
1
2023
2620
0.030
 Why?
Survival Analysis
1
2016
735
0.030
 Why?
Gonioscopy
1
2012
8
0.030
 Why?
Age Distribution
1
2013
198
0.030
 Why?
Choroidal Neovascularization
1
2013
65
0.030
 Why?
Neovascularization, Pathologic
1
2012
168
0.030
 Why?
Retinal Artery
1
2011
5
0.030
 Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
9
0.030
 Why?
Indocyanine Green
1
2011
39
0.020
 Why?
Coloring Agents
1
2011
84
0.020
 Why?
Dopamine Antagonists
1
2011
19
0.020
 Why?
Injections, Intraocular
1
2010
7
0.020
 Why?
Angiography
1
2011
147
0.020
 Why?
Methylprednisolone
1
2010
38
0.020
 Why?
Regional Blood Flow
1
2011
121
0.020
 Why?
Orbit
1
2010
35
0.020
 Why?
Chemotherapy, Adjuvant
1
2011
119
0.020
 Why?
Adrenal Cortex Hormones
1
2011
95
0.020
 Why?
Schizophrenia
1
2011
276
0.020
 Why?
Immunosuppressive Agents
1
2011
248
0.020
 Why?
Sweden
1
2007
10
0.020
 Why?
Sallam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (322) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department